We are live on
!
Find out more
KFC
Klingenstein Fields & Co Portfolio holdings
AUM
$2.86B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.67%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.17B
AUM Growth
+$33.7M
(+1.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
39.91%
Holding
229
New
18
Increased
51
Reduced
70
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$4.56M |
| 2 |
Emerson Electric
EMR
|
+$2.68M |
| 3 |
Dentsply Sirona
XRAY
|
+$1.68M |
| 4 |
SPDR Gold Trust
GLD
|
+$1.48M |
| 5 |
Aptiv
APTV
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$19.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$4.59M |
| 3 |
Crown Castle
CCI
|
+$2.56M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.04M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.77% |
| 2 | Communication Services | 16.87% |
| 3 | Healthcare | 15.71% |
| 4 | Financials | 14.72% |
| 5 | Consumer Staples | 12.49% |
Similar funds
AHSSHC
YC
MSDF
SAI
LIP
DMIC
PFM
AIP
Klingenstein Fields & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Klingenstein Fields & Co held 229 positions worth $2.17B, up 1.6% from $2.14B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Klingenstein Fields & Co's Q3 2016 filing shows 18 new, 51 increased, 70 reduced and 6 closed positions. Its largest new stake was Dentsply Sirona: 27,354 shares worth $1.63M. The largest sale was EMC CORPORATION, an estimated $19.6M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Communication Services and Healthcare.
- Klingenstein Fields & Co's largest Q3 2016 buy was Dentsply Sirona: 27,354 shares worth $1.63M.
- Klingenstein Fields & Co added most to Broadcom in Q3 2016, an estimated $4.56M increase.
- Klingenstein Fields & Co's biggest Q3 2016 reduction was Teva Pharmaceuticals, cutting an estimated $4.59M.
- Klingenstein Fields & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.6M.
- Klingenstein Fields & Co's ten largest holdings make up 40% of its $2.17B portfolio in Q3 2016.
- Klingenstein Fields & Co opened 18 new positions and closed 6 in Q3 2016.
- Klingenstein Fields & Co's portfolio value rose 1.6% quarter-over-quarter to $2.17B.
Based on Klingenstein Fields & Co's 13F filing for Q3 2016, filed 2 Nov 2016.